基本信息
浏览量:4
职业迁徙
个人简介
Harendra's research interests are in the area of synthetic pharmaceutical chemistry, pharmaceutics as applied to nano-carriers, and advanced non-viral drug/gene delivery system design, synthesis and evaluation. His team at PACE have been instrumental in developing highly versatile micro- & nanobubble formulations, which when used in-conjuction with ultrasound, pave the way for improved rates of 'on-demand' drug delivery and release in target tissue. Harendra also has a keen interest in developing bioresponsive drug/gene delivery systems with current engagement with pharma partners, globally, to commercialise his platforms. Separately, Dr Parekh has been developing a program to reformulate TCMs, in collaboration with researchers at a leading Chinese research institute; the outcomes of this work was aired across Asia in a BBC World News story, and showcased (TV & radio) by the Australian Academy of Science, National Touring Series.
Under the supervision of Dr B. Kellam and Dr. S. R. Chhabra he investigated the development of novel linkers for solid phase peptide and glycopeptide synthesis.
Emphasis was on the treatment of age-related macular degeneration and in 2004 he received Uniquest's Trailblazer Prize for commercialisation potential.
Under the supervision of Dr B. Kellam and Dr. S. R. Chhabra he investigated the development of novel linkers for solid phase peptide and glycopeptide synthesis.
Emphasis was on the treatment of age-related macular degeneration and in 2004 he received Uniquest's Trailblazer Prize for commercialisation potential.
研究兴趣
论文共 89 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
International Journal of Pharmaceutics (2024): 124054-124054
Journal of controlled release : official journal of the Controlled Release Society (2023): 452-463
Isaac J Rad, Luke Chapman,Karnaker Reddy Tupally,Martin Veidt,Hussain Al-Sadiq,Robert Sullivan,Harendra S Parekh
Theranosticsno. 11 (2023): 3582-3638
International journal of pharmaceutics (2023): 123582-123582
MOLECULAR PHARMACEUTICSno. 12 (2023): 5954-5980
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn